Jeffrey E. Gershenwald, MD
Jeffrey E. Gershenwald, MD, FACS, is a Professor of Surgery in the Department of Surgical Oncology and a Professor in the Department of Cancer Biology at The University of Texas M. D. Anderson Cancer Center (MDACC) in Houston, Texas. Dr. Gershenwald received his undergraduate degree from Cornell University and his MD from Cornell University Medical College. After completing his general surgery residency at The New York Hospital-Cornell Medical Center, Dr. Gershenwald completed a fellowship in Surgical Oncology at MDACC before joining the faculty there. Dr. Gershenwald holds numerous academic administrative appointments, including serving as Vice-Chair of the Melanoma Committee of the American Joint Committee for Cancer (AJCC) and on the Executive Council for the Society of Surgical Oncology. He is also a Co-Director of the Melanoma SPORE and Co-Director of the Melanoma Informatics, Tissue Resource, and Pathology Core, both at MDACC. Dr. Gershenwald’s research focuses on prognostic assessment in melanoma and molecular mechanisms of melanoma progression. Most recently, Dr. Gershenwald has been a founding member and Co-Chair of the Melanoma Disease Working Group of The Cancer Genome Atlas (TCGA) project. Dr. Gershenwald has published more than 130 articles in peer-reviewed journals, as well as more than 100 editorials, abstracts, invited articles, and other publications. His many honors include the Physician-Scientist Program Award from MDACC, an American Cancer Society Research Scholar Grant Award to examine the “Biology and Significance of Melanoma Lymphatic Metastasis” and, for the past 8 years, Dr. Gershenwald has been listed in America’s Best Doctors.